DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
EVATANEPAG
2
Small molecule
Investigational
Unknown
Unknown
Tibial Fractures
Prostanoid EP2 receptor agonist
EVATANEPAG
×
Maximum Phase:
2
First Approval:
None
UNII:
L266R6E31E
Molecule Type:
Small molecule
Molecular Formula:
C25H28N2O5S
Molecular Weight:
468.58
AlogP:
4.23
PSA:
96.8
HBD:
1.0
HBA:
#RotB:
9.0
Source:
DEFERITAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DEFERITAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
4D8DC53Y1L
Molecule Type:
Small molecule
Molecular Formula:
C18H25NO7S
Molecular Weight:
399.47
AlogP:
1.79
PSA:
106.81
HBD:
2.0
HBA:
#RotB:
12.0
Source:
DECERNOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase JAK3 inhibitor
DECERNOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
MZK2GP0RHK
Molecule Type:
Small molecule
Molecular Formula:
C18H19F3N6O
Molecular Weight:
392.39
AlogP:
3.28
PSA:
95.59
HBD:
3.0
HBA:
#RotB:
6.0
Source:
CE-326597
2
Small molecule
Investigational
Unknown
Unknown
Obesity
Cholecystokinin A receptor agonist
CE-326597
×
Maximum Phase:
2
First Approval:
None
UNII:
1FGZ6L9SF2
Molecule Type:
Small molecule
Molecular Formula:
C37H34N6O2
Molecular Weight:
594.72
AlogP:
6.53
PSA:
87.12
HBD:
1.0
HBA:
#RotB:
8.0
Source:
BISANTRENE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute
Alpha-ketoglutarate-dependent dioxygenase FTO inhibitor
BISANTRENE
×
Maximum Phase:
2
First Approval:
None
UNII:
39C34M111K
Molecule Type:
Small molecule
Molecular Formula:
C22H22N8
Molecular Weight:
398.47
AlogP:
1.76
PSA:
97.56
HBD:
4.0
HBA:
#RotB:
4.0
Source:
PARTHENOLIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
PARTHENOLIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
2RDB26I5ZB
Molecule Type:
Small molecule
Molecular Formula:
C15H20O3
Molecular Weight:
248.32
AlogP:
2.76
PSA:
38.83
HBD:
0.0
HBA:
#RotB:
0.0
Source:
BPN-14770
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BPN-14770
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
JNJ-54861911
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
JNJ-54861911
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IBIPINABANT
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Obesity
Cannabinoid CB1 receptor antagonist
IBIPINABANT
×
Maximum Phase:
2
First Approval:
None
UNII:
O5CSC6WH1T
Molecule Type:
Small molecule
Molecular Formula:
C23H20Cl2N4O2S
Molecular Weight:
487.41
AlogP:
4.76
PSA:
74.13
HBD:
1.0
HBA:
#RotB:
4.0
Source:
ONO-2333MS
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Corticotropin releasing factor receptor 1 antagonist
ONO-2333MS
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C22H27ClN4O
Molecular Weight:
398.94
AlogP:
5.46
PSA:
51.45
HBD:
1.0
HBA:
#RotB:
6.0
Source:
YM-543
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Sodium/glucose cotransporter 2 inhibitor
YM-543
×
Maximum Phase:
2
First Approval:
None
UNII:
KA83KI0EO9
Molecule Type:
Small molecule
Molecular Formula:
C28H37NO7
Molecular Weight:
499.6
AlogP:
1.6
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
4.0
Source:
AVADOMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Renal Insufficiency; Melanoma
Unknown
AVADOMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
28DZS29F59
Molecule Type:
Small molecule
Molecular Formula:
C14H14N4O3
Molecular Weight:
286.29
AlogP:
0.26
PSA:
107.08
HBD:
2.0
HBA:
#RotB:
1.0
Source:
EMIVIRINE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Human immunodeficiency virus type 1 reverse transcriptase inhibitor
EMIVIRINE
×
Maximum Phase:
2
First Approval:
None
UNII:
X87G8IX72O
Molecule Type:
Small molecule
Molecular Formula:
C17H22N2O3
Molecular Weight:
302.37
AlogP:
2.24
PSA:
64.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
CK-2127107
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CK-2127107
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
INDISULAM
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Stomach Neoplasms; Breast Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Kidney Neoplasms; Leukemia; Melanoma
Unknown
INDISULAM
×
Maximum Phase:
2
First Approval:
None
UNII:
WJ98J3NM90
Molecule Type:
Small molecule
Molecular Formula:
C14H12ClN3O4S2
Molecular Weight:
385.85
AlogP:
2.27
PSA:
122.12
HBD:
3.0
HBA:
#RotB:
4.0
Source:
METHYLINOSITOL
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
METHYLINOSITOL
×
Maximum Phase:
2
First Approval:
None
UNII:
TF9HZN9T0M
Molecule Type:
Small molecule
Molecular Formula:
C7H14O6
Molecular Weight:
194.18
AlogP:
-3.18
PSA:
110.38
HBD:
5.0
HBA:
#RotB:
1.0
Source:
LUTEOLIN
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
LUTEOLIN
×
Maximum Phase:
2
First Approval:
None
UNII:
KUX1ZNC9J2
Molecule Type:
Small molecule
Molecular Formula:
C15H10O6
Molecular Weight:
286.24
AlogP:
2.28
PSA:
111.13
HBD:
4.0
HBA:
#RotB:
1.0
Source:
GOSSYPOL ACETIC ACID
2
Small molecule
Investigational
Unknown
Unknown
Central Nervous System Neoplasms; Leukemia, Lymphocytic, Chronic, B-Cell; Multiple Myeloma; Adrenal Cortex Neoplasms; Glioblastoma; Gliosarcoma; Small Cell Lung Carcinoma
Unknown
GOSSYPOL ACETIC ACID
×
Maximum Phase:
2
First Approval:
None
UNII:
S7RL72610R
Molecule Type:
Small molecule
Molecular Formula:
C42H42O14
Molecular Weight:
770.78
AlogP:
7.7
PSA:
191.94
HBD:
0.0
HBA:
#RotB:
11.0
Source:
VENGLUSTAT MALATE
2
Small molecule
Investigational
Unknown
Unknown
Fabry Disease; Gaucher Disease; Parkinsonian Disorders; Polycystic Kidney, Autosomal Dominant
Unknown
VENGLUSTAT MALATE
×
Maximum Phase:
2
First Approval:
None
UNII:
94855LQZ8D
Molecule Type:
Small molecule
Molecular Formula:
C24H30FN3O7S
Molecular Weight:
523.58
AlogP:
4.0
PSA:
54.46
HBD:
1.0
HBA:
#RotB:
4.0
Source:
GSK-2269557
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
PI3-kinase p110-delta subunit inhibitor
GSK-2269557
×
Maximum Phase:
2
First Approval:
None
UNII:
II4WQU7U3O
Molecule Type:
Small molecule
Molecular Formula:
C26H29ClN6O
Molecular Weight:
477.01
AlogP:
4.89
PSA:
76.98
HBD:
2.0
HBA:
#RotB:
5.0
Source:
OLCEGEPANT
2
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
OLCEGEPANT
×
Maximum Phase:
2
First Approval:
None
UNII:
WOA5J8TX6M
Molecule Type:
Small molecule
Molecular Formula:
C38H47Br2N9O5
Molecular Weight:
869.66
AlogP:
4.41
PSA:
176.47
HBD:
5.0
HBA:
#RotB:
12.0
Source:
CAMPTOTHECIN-20-O-PROPIONATE
2
Small molecule
Investigational
Unknown
Unknown
Lymphoma; Neoplasms; Small Cell Lung Carcinoma
DNA topoisomerase I inhibitor
CAMPTOTHECIN-20-O-PROPIONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
4S145C552U
Molecule Type:
Small molecule
Molecular Formula:
C23H20N2O5
Molecular Weight:
404.42
AlogP:
3.04
PSA:
87.49
HBD:
0.0
HBA:
#RotB:
3.0
Source:
SARCOSINE
2
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder; Depressive Disorder, Major; Mental Disorders; Schizophrenia
Unknown
SARCOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
Z711V88R5F
Molecule Type:
Small molecule
Molecular Formula:
C3H7NO2
Molecular Weight:
89.09
AlogP:
-0.71
PSA:
49.33
HBD:
2.0
HBA:
#RotB:
2.0
Source:
IOWH-032
2
Small molecule
Investigational
Unknown
Unknown
Digestive System Diseases
Cystic fibrosis transmembrane conductance regulator inhibitor
IOWH-032
×
Maximum Phase:
2
First Approval:
None
UNII:
8Y3GDT6YWV
Molecule Type:
Small molecule
Molecular Formula:
C22H15Br2N3O4
Molecular Weight:
545.19
AlogP:
5.69
PSA:
97.48
HBD:
2.0
HBA:
#RotB:
6.0
Source:
TNP-2092
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TNP-2092
×
Maximum Phase:
2
First Approval:
None
UNII:
W2P7EF7O6O
Molecule Type:
Small molecule
Molecular Formula:
C65H81FN6O15
Molecular Weight:
1205.39
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
PCI-27483
2
Small molecule
Investigational
Unknown
Unknown
Pancreatic Neoplasms
Coagulation factor VII inhibitor
PCI-27483
×
Maximum Phase:
2
First Approval:
None
UNII:
6073LCU8U9
Molecule Type:
Small molecule
Molecular Formula:
C26H24N6O9S
Molecular Weight:
596.58
AlogP:
0.83
PSA:
282.87
HBD:
9.0
HBA:
#RotB:
10.0
Source:
CYTOSINE
2
Small molecule
Investigational
Unknown
Unknown
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
CYTOSINE
×
Maximum Phase:
2
First Approval:
None
UNII:
8J337D1HZY
Molecule Type:
Small molecule
Molecular Formula:
C4H5N3O
Molecular Weight:
111.1
AlogP:
-0.65
PSA:
71.77
HBD:
2.0
HBA:
#RotB:
0.0
Source:
DERSALAZINE
2
Small molecule
Investigational
Unknown
Unknown
Colitis, Ulcerative
Unknown
DERSALAZINE
×
Maximum Phase:
2
First Approval:
None
UNII:
WS1IH75AJT
Molecule Type:
Small molecule
Molecular Formula:
C36H33N5O4
Molecular Weight:
599.69
AlogP:
7.53
PSA:
120.38
HBD:
2.0
HBA:
#RotB:
8.0
Source:
BRILANESTRANT
2
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms
Estrogen receptor degrader
BRILANESTRANT
×
Maximum Phase:
2
First Approval:
None
UNII:
9MM2R1A06R
Molecule Type:
Small molecule
Molecular Formula:
C26H20ClFN2O2
Molecular Weight:
446.91
AlogP:
6.82
PSA:
65.98
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ENCLOMIPHENE
2
Small molecule
Investigational
Unknown
Unknown
Hypogonadism; Obesity
Estrogen receptor alpha modulator
ENCLOMIPHENE
×
Maximum Phase:
2
First Approval:
None
UNII:
R6D2UI4FLS
Molecule Type:
Small molecule
Molecular Formula:
C26H28ClNO
Molecular Weight:
405.97
AlogP:
6.56
PSA:
12.47
HBD:
0.0
HBA:
#RotB:
9.0
Source:
LARSUCOSTEROL
2
Small molecule
Investigational
Unknown
Unknown
COVID-19; Liver Diseases, Alcoholic; Non-alcoholic Fatty Liver Disease; Cholangitis, Sclerosing; Hepatitis, Alcoholic; Psoriasis; Severe Acute Respiratory Syndrome
Unknown
LARSUCOSTEROL
×
Maximum Phase:
2
First Approval:
None
UNII:
UGX2V7MGMZ
Molecule Type:
Small molecule
Molecular Formula:
C27H46O5S
Molecular Weight:
482.73
AlogP:
6.33
PSA:
83.83
HBD:
2.0
HBA:
#RotB:
7.0
Source:
AVAGACESTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Gamma-secretase inhibitor
AVAGACESTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
TQ44WWY45Q
Molecule Type:
Small molecule
Molecular Formula:
C20H17ClF4N4O4S
Molecular Weight:
520.89
AlogP:
3.92
PSA:
119.39
HBD:
1.0
HBA:
#RotB:
9.0
Source:
AMMONIUM TRICHLOROTELLURATE
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections; Macular Degeneration; Alopecia; Condylomata Acuminata; Dermatitis, Atopic; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Psoriasis
Unknown
AMMONIUM TRICHLOROTELLURATE
×
Maximum Phase:
2
First Approval:
None
UNII:
708681952A
Molecule Type:
Small molecule
Molecular Formula:
C2H8Cl3NO2Te
Molecular Weight:
312.05
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
BMS-646256
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-646256
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZD6765
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD6765
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
94
95
96
97
98
99
100
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA